MRK analyst scorecard · Merck & Co.
52 rating changes on MRK in the last 12 months. 77% of bullish calls were right at 30 days. Street grade A on 31 scored calls. Consensus target $153, 6% above the last close.
Graded through 2026-09-14 · last close $145.03 (2026-09-14). Rebuilt every morning.
Street grade
A 74.2%
Rating changes, 12 mo
52
Bullish calls right at 30d
76.7% of 30
Bearish calls right at 30d
—
Consensus target
$153 +5.5%
Firms covering
26
Price targets hit (90d)
37.0% of 27
Holds on MRK, read: 1 cut to or raised to Hold (graded as the change) · 2 Holds whose target leaned 10%+ one way (graded that way) · 10 true Holds, not graded.
The chase: the 5 upgrades on MRK landed after an average +11.8% run in the prior 30 days, and the stock averaged +16.0% in the 90 days after.
Firm by firm
| Firm | Calls | Scored | Right | Accuracy | Grade | Avg 30d | Avg 90d | Latest | Date | Target |
|---|---|---|---|---|---|---|---|---|---|---|
| Wells Fargo | 6 | 5 | 4 | 80.0% | A | +2.5% | +9.3% | Overweight | 2026-09-04 | $170 |
| Morgan Stanley | 4 | 1 | 1 | — | — | +12.5% | +26.5% | Overweight | 2026-08-20 | $179 |
| BMO Capital | 3 | 2 | 2 | — | — | +7.9% | +13.7% | Outperform | 2026-08-20 | $170 |
| Wolfe Research | 2 | 1 | 1 | — | — | +6.0% | +11.0% | Outperform | 2026-08-25 | $180 |
| Argus Research | 2 | 1 | 1 | — | — | +11.0% | — | Buy | 2026-08-25 | $170 |
| Goldman Sachs | 2 | 1 | 1 | — | — | +5.4% | +20.2% | Buy | 2026-08-21 | $160 |
| Bank of America | 2 | 2 | 2 | — | — | +5.9% | +15.1% | Buy | 2026-06-30 | $141 |
| Scotiabank | 2 | 2 | 2 | — | — | +3.8% | +19.2% | Sector Outperform | 2026-06-30 | $155 |
| Daiwa Capital | 1 | 1 | 1 | — | — | +8.3% | — | Outperform | 2026-08-12 | $143 |
| CICC | 1 | 1 | 1 | — | — | +8.7% | — | Outperform | 2026-06-24 | $138 |
| Deutsche Bank | 1 | 1 | 1 | — | — | +4.4% | +26.1% | Hold | 2025-11-18 | $111 |
| Guggenheim | 4 | 3 | 2 | — | — | +6.8% | -7.9% | Buy | 2026-09-08 | $170 |
| UBS | 3 | 2 | 1 | — | — | +3.3% | +6.5% | Buy | 2026-08-20 | $175 |
| Barclays | 2 | 2 | 1 | — | — | +4.2% | -5.2% | Overweight | 2026-07-29 | $150 |
| JPMorgan | 2 | 2 | 1 | — | — | +0.6% | +4.9% | Overweight | 2026-07-13 | $140 |
| RBC Capital | 4 | 3 | 1 | — | — | -2.1% | +3.7% | Sector Perform | 2026-08-20 | $150 |
| Citigroup | 4 | 0 | 0 | — | — | +5.8% | +1.8% | Neutral | 2026-03-20 | $125 |
| Cantor Fitzgerald | 2 | 0 | 0 | — | — | -0.5% | -4.4% | Neutral | 2026-07-06 | $120 |
| HSBC | 1 | 0 | 0 | — | — | — | — | Buy | 2026-09-10 | $172 |
| Leerink Partners | 1 | 0 | 0 | — | — | — | — | Outperform | 2026-09-09 | $161 |
| Freedom Broker | 1 | 0 | 0 | — | — | -1.2% | -5.4% | Hold | 2026-02-09 | $110 |
| TD Cowen | 1 | 0 | 0 | — | — | +11.3% | +7.0% | Hold | 2026-01-20 | $120 |
| Berenberg | 1 | 1 | 0 | — | — | +4.5% | +21.1% | Hold | 2025-09-17 | $90 |
Dimmed rows have fewer than 4 scored calls on MRK — too few to grade.
Every call, last 12 months
| Date | Firm | Change | Action | Graded as | Price at call | Run before | +30d | +60d | +90d | Target · 90d check | Hit |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 | HSBC | Buy → Buy | maintained | Bullish | $144.71 | +11.0% | — | — | — | $172 | pending |
| 2026-09-09 | Leerink Partners | Outperform → Outperform | maintained | Bullish | $147.53 | +12.7% | — | — | — | $161 | pending |
| 2026-09-08 | Guggenheim | Buy → Buy | maintained | Bullish | $148.46 | +15.5% | — | — | — | $170 | pending |
| 2026-09-04 | Wells Fargo | Overweight → Overweight | maintained | Bullish | $150.33 | +17.1% | — | — | — | $170 | pending |
| 2026-08-25 | Wolfe Research | Outperform → Outperform | maintained | Bullish | $156.45 | +19.4% | — | — | — | $180 | pending |
| 2026-08-25 | Argus Research | Buy → Buy | maintained | Bullish | $156.45 | +19.4% | — | — | — | $170 | pending |
| 2026-08-21 | Goldman Sachs | Buy → Buy | maintained | Bullish | $152.55 | +19.7% | — | — | — | $160 | pending |
| 2026-08-20 | BMO Capital | Outperform → Outperform | maintained | Bullish | $148.99 | +18.0% | — | — | — | $170 | pending |
| 2026-08-20 | UBS | Buy → Buy | maintained | Bullish | $148.99 | +18.0% | — | — | — | $175 | pending |
| 2026-08-20 | RBC Capital | Outperform → Sector Perform | downgrade | Bearish · cut to Sector Perform | $148.99 | +18.0% | — | — | — | $150 | pending |
| 2026-08-20 | Morgan Stanley | Equal-Weight → Overweight | upgrade | Bullish | $148.99 | +18.0% | — | — | — | $179 | pending |
| 2026-08-12 | Daiwa Capital | Neutral → Outperform | upgrade | Bullish | $132.92 | +7.2% | +8.3% | — | — | $143 | ✓ |
| 2026-08-11 | Argus Research | Buy → Buy | maintained | Bullish | $130.42 | +5.6% | +11.0% | — | — | $145 | ✓ |
| 2026-08-05 | Guggenheim | Buy → Buy | maintained | Bullish | $128.33 | +1.2% | +17.1% | — | — | $146 | ✓ |
| 2026-07-29 | Barclays | Overweight → Overweight | maintained | Bullish | $130.36 | +0.8% | +13.8% | — | — | $150 | ✓ |
| 2026-07-13 | JPMorgan | Overweight → Overweight | maintained | Bullish | $124.03 | +4.2% | +7.2% | +16.0% | — | $140 | ✓ |
| 2026-07-13 | BMO Capital | Outperform → Outperform | maintained | Bullish | $124.03 | +4.2% | +7.2% | +16.0% | — | $142 | ✓ |
| 2026-07-13 | Guggenheim | Buy → Buy | maintained | Bullish | $124.03 | +4.2% | +7.2% | +16.0% | — | $145 | ✓ |
| 2026-07-09 | Morgan Stanley | Equal-Weight → Equal-Weight | maintained | True hold · target -9% | $125.07 | +4.6% | +4.7% | +18.7% | — | $113 | not graded |
| 2026-07-08 | RBC Capital | Outperform → Outperform | reiterated | Bullish | $125.99 | +5.4% | +2.1% | +17.8% | — | $142 | ✓ |
| 2026-07-08 | Wells Fargo | Overweight → Overweight | maintained | Bullish | $125.99 | +5.4% | +2.1% | +17.8% | — | $150 | ✓ |
| 2026-07-06 | Cantor Fitzgerald | Neutral → Neutral | reiterated | True hold · target -5% | $126.78 | +5.0% | +1.2% | +18.6% | — | $120 | not graded |
| 2026-06-30 | Bank of America | Buy → Buy | maintained | Bullish | $128.50 | +8.2% | +1.0% | +15.0% | — | $141 | ✓ |
| 2026-06-30 | Scotiabank | Sector Outperform → Sector Outperform | maintained | Bullish | $128.50 | +8.2% | +1.0% | +15.0% | — | $155 | ✓ |
| 2026-06-24 | CICC | Outperform | initiated | Bullish | $120.60 | -1.5% | +8.7% | +24.9% | — | $138 | ✓ |
| 2026-05-01 | Wells Fargo | Overweight → Overweight | maintained | Bullish | $112.16 | -7.2% | +2.7% | +14.6% | +15.7% | $145 close | ✓ |
| 2026-04-13 | UBS | Buy → Buy | maintained | Bullish | $120.15 | +3.9% | -5.6% | -0.9% | +3.2% | $145 missed | ✗ |
| 2026-04-06 | JPMorgan | Overweight → Overweight | maintained | Bullish | $120.85 | +4.4% | -6.0% | -0.1% | +4.9% | $135 missed | ✗ |
| 2026-03-30 | RBC Capital | Outperform → Outperform | reiterated | Bullish | $118.10 | -4.6% | -6.0% | +0.5% | +9.6% | $142 missed | ✗ |
| 2026-03-20 | Citigroup | Neutral → Neutral | maintained | True hold · target +9% | $114.18 | -6.2% | +2.6% | +0.1% | -0.3% | $125 missed | not graded |
| 2026-03-12 | Wells Fargo | Overweight → Overweight | maintained | Bullish | $115.91 | -1.1% | +3.7% | -4.0% | +2.7% | $150 missed | ✓ |
| 2026-02-25 | RBC Capital | Outperform | initiated | Bullish | $122.46 | +14.0% | -2.3% | -10.0% | -2.2% | $142 missed | ✗ |
| 2026-02-20 | Barclays | Overweight | initiated | Bullish | $122.26 | +10.0% | -5.4% | -7.9% | -5.2% | $140 missed | ✗ |
| 2026-02-09 | Freedom Broker | Hold → Hold | maintained | True hold · target -6% | $117.65 | +6.4% | -1.2% | +3.2% | -5.4% | $110 hit | not graded |
| 2026-02-06 | Guggenheim | Buy → Buy | maintained | Bullish | $121.93 | +12.3% | -4.0% | -2.2% | -7.9% | $140 missed | ✗ |
| 2026-02-04 | Citigroup | Neutral → Neutral | maintained | True hold · target +1% | $118.33 | +10.1% | -2.1% | +2.1% | -4.4% | $120 missed | not graded |
| 2026-02-04 | Cantor Fitzgerald | Neutral → Neutral | maintained | True hold · target +1% | $118.33 | +10.1% | -2.1% | +2.1% | -4.4% | $120 missed | not graded |
| 2026-02-04 | Wells Fargo | Overweight → Overweight | maintained | Bullish | $118.33 | +10.1% | -2.1% | +2.1% | -4.4% | $135 missed | ✗ |
| 2026-01-27 | Citigroup | Neutral → Neutral | maintained | True hold · target +6% | $107.92 | +1.1% | +10.5% | +9.4% | +2.1% | $115 hit | not graded |
| 2026-01-20 | TD Cowen | Hold → Hold | maintained | True hold · target +9% | $109.45 | +8.3% | +11.3% | +5.7% | +7.0% | $120 hit | not graded |
| 2026-01-08 | Wolfe Research | Peer Perform → Outperform | upgrade | Bullish | $110.99 | +14.6% | +6.0% | +5.5% | +11.0% | $135 close | ✓ |
| 2026-01-07 | UBS | Buy → Buy | maintained | Bullish | $108.60 | +9.8% | +12.3% | +7.8% | +9.8% | $130 missed | ✓ |
| 2026-01-07 | Citigroup | Neutral → Neutral | maintained | True hold · target +1% | $108.60 | +9.8% | +12.3% | +7.8% | +9.8% | $110 missed | not graded |
| 2025-12-18 | BMO Capital | Market Perform → Outperform | upgrade | Bullish | $100.69 | +4.4% | +8.7% | +20.7% | +13.7% | $130 missed | ✓ |
| 2025-12-15 | Bank of America | Buy → Buy | maintained | Bullish | $100.26 | +7.9% | +10.7% | +21.1% | +15.1% | $120 hit | ✓ |
| 2025-12-12 | Morgan Stanley | Equal-Weight → Equal-Weight | maintained | True hold · target +1% | $100.30 | +9.7% | +8.9% | +16.8% | +15.6% | $102 missed | not graded |
| 2025-12-04 | Scotiabank | Sector Outperform → Sector Outperform | maintained | Bullish | $100.89 | +20.3% | +6.5% | +12.4% | +19.2% | $120 hit | ✓ |
| 2025-12-02 | Goldman Sachs | Buy → Buy | maintained | Bullish | $101.03 | +17.5% | +5.4% | +12.2% | +20.2% | $120 hit | ✓ |
| 2025-11-24 | Wells Fargo | Equal-Weight → Overweight | upgrade | Bullish | $100.40 | +14.8% | +6.0% | +7.8% | +23.3% | $125 hit | ✓ |
| 2025-11-18 | Deutsche Bank | Hold → Hold | maintained | Leans bullish · Hold, target +15% | $96.43 | +13.7% | +4.4% | +13.5% | +26.1% | $111 hit | ✓ |
| 2025-11-03 | Morgan Stanley | Equal-Weight → Equal-Weight | maintained | Leans bullish · Equal-Weight, target +21% | $82.49 | -7.5% | +24.0% | +29.1% | +37.4% | $100 hit | ✓ |
| 2025-09-17 | Berenberg | Buy → Hold | downgrade | Bearish · cut to Hold | $81.14 | — | +4.5% | +14.4% | +21.1% | $90 hit | ✗ |
Also in Pharma
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How the grading works
Every sell-side rating change from the last 365 days is priced the day it lands and checked again 30, 60 and 90 days later. A call is a hit when the stock moved in the called direction at 30 days. Buy- and Sell-side ratings call their own direction. A Hold is read, not waved through: a downgrade to Hold is graded as a bearish call and an upgrade to Hold as a bullish one, and a maintained Hold whose price target sits 10%+ above the price leans bullish (10%+ below, leans bearish) and is graded that way. A Hold with a target close to the price is a true Hold and is not graded at all. Every call with a price target also gets a target check 90 days later: hit (reached it or within 5%), close (covered at least half the distance) or missed. A firm's accuracy on a single name prints only after 4 scored calls, and a firm gets its own page only after 10 scored calls across every covered name — below that a percentage is noise. "Run before the call" is the stock's move over the 30 calendar days before the rating landed. Data: Yahoo Finance rating history and daily closes, rebuilt each morning. Nothing on this page is advice.
Get the 7 AM brief
The AM take, today's docket and the Street's calls — one email, weekdays, before the open.